Mounjaro Single-Dose Pen
  1. Home
  2. Mounjaro
  3. Mounjaro Single-Dose Pen

Mounjaro Single-Dose Pen

Mounjaro Single-Dose Pen is a prescription dual GIP and GLP-1 receptor agonist prefilled injection pen used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is designed to deliver a single prescribed dose of tirzepatide through once-weekly subcutaneous injection. The ready-to-use pen provides accurate, reliable, and convenient medication administration.

BUY NOW

Category

Mounjaro Single-Dose Pen contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The sterile prefilled single-dose pen is engineered for precise subcutaneous administration and is available in multiple dosage strengths to support individualized treatment according to the prescribed dose-escalation schedule. Manufactured under stringent pharmaceutical quality standards, the ready-to-use injection pen delivers dependable clinical performance while eliminating the need for manual medication preparation. Mounjaro Single-Dose Pen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro Single-Dose Pen
Active Ingredient Tirzepatide
Dosage Form Sterile Single-Dose Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro Single-Dose Pen, Tirzepatide Single-Dose Pen, Mounjaro Prefilled Pen, Tirzepatide Injection Pen, Weekly Tirzepatide Injection, GIP GLP-1 Injection Pen, Ready-to-Use Injection Pen